Fast biologic sales may see European Pharma cross US Firms

Changing landscape of the biologic sector is going to be pivotal in driving sales for European pharma companies and helping them surpass the US counterparts.

EU Pharma Legislation Agenda: Easy Access To Meds In The UK

EU pharmaceutical legislation reform aims to boost medicine accessibility, and affordability while addressing slow and fragmented approval processes in the UK.

Stakes Are High As Swiss Pharma Sector Negotiates With EU

As the mutual recognition agreement between EU & Switzerland expires in a few years, it is important that the latter does a balancing act for desired outcomes.

Booming Pharma Industry of India: A Review of Quarter1 2023

Pharma companies target the Indian market for declining revenues in the US, Europe, and emerging markets, and the rapid growth and strong performance in India.

Consumer Demands Drive ESG Integration In Global Healthcare

Pharmaceutical industry integrates ESG standards to meet consumer demand for ethical and environmentally responsible practices in the global healthcare sector.